Significant treatment benefits seen at 18 months; in addition, risk for experiencing subsequent end points lower with valacyclovir. HealthDay News — One year of valacyclovir is beneficial for patients ...

Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles affects the eye, according to ...

Low-dose suppressive valacyclovir treatment of herpes zoster ophthalmicus (HZO) did not show significant benefits at 12 months but showed treatment superiority at 18 months and a reduction in the ...

Taking an antiviral medication for a year may prevent vision damage associated with shingles that affects the eye, according to new research led by faculty from the Perelman School of Medicine at the ...

Taking an antiviral medication for a year may prevent vision damage associated with shingles that affects the eye, according to new research led by faculty from the Perelman School of Medicine at the ...

There’s a potential new treatment for people who develop shingles that spread to the eye. Doctors say about 8% of shingles cases impact the eyes, and now, for the first time there’s a new treatment ...

Are Abreva and Valtrex the Same Thing? Valtrex valacyclovir and Abreva docosanol cream are antiviral medications used to treat herpes labialis cold sores. Valtrex is also used to treat infections with ...